Sygnature Discovery

Drug discovery services

sygnaturediscovery.com
Date Invested
September 2017
Status
Current
Sector

At a glance

>200
PhD-qualified scientists
>600,000
test tubes used each year
50
new scientists hired per year

Sygnature is a leading provider of outsourced drug discovery services to UK and overseas biotech and pharma companies. The company employs over 220 staff, the majority of whom hold PhDs.

Sygnature’s people work in partnership with its clients to support them in identifying and developing new molecules in the early stages of the drug development process.

Our partnership

We’re working in partnership with founding CEO, Simon Hirst, and the team to accelerate growth by expanding the business’s international reach and broadening the range of services it provides to its clients. Together we are assessing a number of potential acquisition opportunities, with the first having been completed in the first year of our investment.

"We’re excited to be working with Phoenix – our partnership will give us the investment we need to further expand our business and provide a broader range of services for our customers.”

Simon Hirst, CEO of Sygnature

See more of our companies

Signum Technology
Flow control products
Capital Economics
Independent macro-economic research provider
Rayner Surgical Group
Developer and manufacturer of intra-ocular lenses
Discover more